Kornélia Szebényi

University of Cambridge — United Kingdom

Medicine · Health Sciences

17h-index1.0kcitations47works2.72yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Drug Transport and Resistance Mechanisms(23), Pluripotent Stem Cells Research(10), RNA Interference and Gene Delivery(8), Radiopharmaceutical Chemistry and Applications(7), Computational Drug Discovery Methods(5)

Publications47 total

Next-Gen Stroke Models: The Promise of Assembloids and Organ-on-a-Chip Systems
Cells·2025Open Access
Origin and cell type specificity of mitochondrial DNA mutations in <i>C9ORF72</i> ALS-FTLD human brain organoids
Science Advances·2025· 6 citedOpen Access
Inhibition of <i>PHLDA3</i> expression in human superoxide dismutase 1-mutant amyotrophic lateral sclerosis astrocytes protects against neurotoxicity
Brain Communications·2024· 2 citedOpen Access
Effective targeting of breast cancer by the inhibition of P-glycoprotein mediated removal of toxic lipid peroxidation byproducts from drug tolerant persister cells
Drug Resistance Updates·2023· 47 citedOpen Access
A human proteogenomic-cellular framework identifies KIF5A as a modulator of astrocyte process integrity with relevance to ALS
Communications Biology·2023· 11 citedOpen Access
Figure S4 from Identification and Validation of Compounds Selectively Killing Resistant Cancer: Delineating Cell Line–Specific Effects from P-Glycoprotein–Induced Toxicity
2023Open Access
Figure S4 from Identification and Validation of Compounds Selectively Killing Resistant Cancer: Delineating Cell Line–Specific Effects from P-Glycoprotein–Induced Toxicity
2023Open Access
Figure S2 from Identification and Validation of Compounds Selectively Killing Resistant Cancer: Delineating Cell Line–Specific Effects from P-Glycoprotein–Induced Toxicity
2023Open Access
Supplementary Table 1 from Identification and Validation of Compounds Selectively Killing Resistant Cancer: Delineating Cell Line–Specific Effects from P-Glycoprotein–Induced Toxicity
2023Open Access
Figure S2 from Identification and Validation of Compounds Selectively Killing Resistant Cancer: Delineating Cell Line–Specific Effects from P-Glycoprotein–Induced Toxicity
2023Open Access
Figure S1 from Identification and Validation of Compounds Selectively Killing Resistant Cancer: Delineating Cell Line–Specific Effects from P-Glycoprotein–Induced Toxicity
2023Open Access
Data from Identification and Validation of Compounds Selectively Killing Resistant Cancer: Delineating Cell Line–Specific Effects from P-Glycoprotein–Induced Toxicity
2023Open Access
Figure S1 from Identification and Validation of Compounds Selectively Killing Resistant Cancer: Delineating Cell Line–Specific Effects from P-Glycoprotein–Induced Toxicity
2023Open Access
Supplementary Table 1 from Identification and Validation of Compounds Selectively Killing Resistant Cancer: Delineating Cell Line–Specific Effects from P-Glycoprotein–Induced Toxicity
2023Open Access
Figure S3 from Identification and Validation of Compounds Selectively Killing Resistant Cancer: Delineating Cell Line–Specific Effects from P-Glycoprotein–Induced Toxicity
2023Open Access
Data from Identification and Validation of Compounds Selectively Killing Resistant Cancer: Delineating Cell Line–Specific Effects from P-Glycoprotein–Induced Toxicity
2023Open Access
Figure S3 from Identification and Validation of Compounds Selectively Killing Resistant Cancer: Delineating Cell Line–Specific Effects from P-Glycoprotein–Induced Toxicity
2023Open Access
Comparison of Different Clinical Chemotherapeutical Agents’ Toxicity and Cell Response on Mesenchymal Stem Cells and Cancer Cells
Cells·2022· 4 citedOpen Access
P-Glycoprotein Activity at Diagnosis Does Not Predict Therapy Outcome and Survival in Canine B-Cell Lymphoma
Cancers·2022· 2 citedOpen Access
Human ALS/FTD brain organoid slice cultures display distinct early astrocyte and targetable neuronal pathology
Nature Neuroscience·2021· 158 citedOpen Access
page 1 of 3Next →

Frequent Co-authors

Gergely Szakács(25), András Füredi(23), Balázs Sarkadi(19), Ágota Apáti(18), József Tóvári(17), Tamás I. Orbán(17), Szilárd Tóth(15), Veronika F.S. Pape(14), Zsuzsa Erdei(14), Nóra Kucsma(14), Dóra Türk(13), László Cervenak(13), György Várady(11), Adrienn Péntek(8), László Homolya(7), András Lakatos(4), Péter Vajdovich(4), Orsolya Kolacsek(4), Nóra Varga(4), George M. Gibbons(3)